This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Morgan Stanley Senior Funding, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Patrick Engelberts
Introduction
Patrick Engelberts is a notable inventor based in Amersfoort, Netherlands. He has made significant strides in the field of cancer treatment through his innovative research and development. His work focuses on the application of antibodies in medical therapies, showcasing his commitment to advancing healthcare solutions.
Latest Patents
Patrick Engelberts holds a patent titled "Method of Treating Cancer by Administering an Antibody Which Binds to 5T4." This patent represents a crucial step in the fight against cancer, as it explores the potential of targeted therapies to improve patient outcomes. With 1 patent to his name, Engelberts is making a meaningful impact in the medical field.
Career Highlights
Engelberts is currently employed at Morgan Stanley Senior Funding, Inc., where he continues to contribute to innovative projects. His role at the company allows him to collaborate with other talented professionals in the industry, further enhancing his expertise and influence.
Collaborations
Some of his notable coworkers include David Satijn and Esther CW Breij. Their collaboration fosters a dynamic environment for innovation and research, enabling them to tackle complex challenges in the field of cancer treatment.
Conclusion
Patrick Engelberts exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. His contributions through patents and collaborations highlight the importance of research and development in improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile